PT1496891E - Métodos para modulação de fototoxicidade - Google Patents

Métodos para modulação de fototoxicidade Download PDF

Info

Publication number
PT1496891E
PT1496891E PT03728425T PT03728425T PT1496891E PT 1496891 E PT1496891 E PT 1496891E PT 03728425 T PT03728425 T PT 03728425T PT 03728425 T PT03728425 T PT 03728425T PT 1496891 E PT1496891 E PT 1496891E
Authority
PT
Portugal
Prior art keywords
modulating
methods
phototoxicity
enhance
ultraviolet light
Prior art date
Application number
PT03728425T
Other languages
English (en)
Inventor
G T Wondrak
Michael J Roberts
Moonsun Kim
M K Jacobson
E L Jacobson
Original Assignee
Univ Arizona State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona State filed Critical Univ Arizona State
Publication of PT1496891E publication Critical patent/PT1496891E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Photovoltaic Devices (AREA)
  • Pyridine Compounds (AREA)
PT03728425T 2002-04-19 2003-04-17 Métodos para modulação de fototoxicidade PT1496891E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37403302P 2002-04-19 2002-04-19

Publications (1)

Publication Number Publication Date
PT1496891E true PT1496891E (pt) 2011-09-02

Family

ID=29251125

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03728425T PT1496891E (pt) 2002-04-19 2003-04-17 Métodos para modulação de fototoxicidade

Country Status (17)

Country Link
US (3) US6992071B2 (pt)
EP (1) EP1496891B1 (pt)
JP (2) JP4527405B2 (pt)
CN (1) CN1298321C (pt)
AT (1) ATE516802T1 (pt)
AU (1) AU2003234119B2 (pt)
CA (2) CA2482320C (pt)
CY (1) CY1112194T1 (pt)
DK (1) DK1496891T3 (pt)
ES (1) ES2367258T3 (pt)
HK (1) HK1077761B (pt)
IL (2) IL164560A0 (pt)
MX (1) MXPA04010228A (pt)
NZ (1) NZ535982A (pt)
PT (1) PT1496891E (pt)
RU (1) RU2301800C2 (pt)
WO (1) WO2003088909A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04010228A (es) * 2002-04-19 2005-06-08 Univ Arizona Metodos para modular la fotoxicidad.
WO2009112360A1 (en) * 2008-03-10 2009-09-17 Basf Se Encapsulated phase change materials in seed coatings
CN102365086A (zh) * 2009-03-30 2012-02-29 株式会社资生堂 紫外线损伤减轻用组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310461A (en) * 1980-06-23 1982-01-12 E. R. Squibb & Sons, Inc. Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US6309440B1 (en) * 1998-08-25 2001-10-30 Thomas T. Yamashita Method and composition for promoting and controlling growth of plants
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
JPH0797322A (ja) * 1993-09-29 1995-04-11 Shiseido Co Ltd 一重項酸素消去剤
US5681554A (en) * 1995-06-28 1997-10-28 Cosmair, Inc. Composition for treating hair and method for using the same
US6013250A (en) * 1995-06-28 2000-01-11 L'oreal S. A. Composition for treating hair against chemical and photo damage
JP2961074B2 (ja) * 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
JPH09249567A (ja) * 1996-01-12 1997-09-22 Otsuka Pharmaceut Co Ltd 医薬組成物
DE69726144T9 (de) * 1996-05-07 2004-09-09 Bernstein, Eric F. Topische verwendung von tempol zur vorbeugung der lichtalterung
US20010056085A1 (en) * 1996-07-09 2001-12-27 Avner Ramu Methods of using vesicant drug formulations
US6274564B1 (en) * 1996-09-18 2001-08-14 William J. Sarill Compositions of cobalamin and related corrinoids, and uses thereof
CA2285343A1 (en) * 1997-03-31 1998-10-08 Wakamoto Pharmaceutical Co., Ltd. Biphenyl derivatives and medicinal compositions
US6103487A (en) * 1997-08-27 2000-08-15 Merck & Co., Inc. Method of treating cancer
FR2775595B1 (fr) * 1998-03-09 2000-05-05 Seppic Sa Composition synergique comprenant un compose a structure lipoaminoacide et un extrait de menuphar
JPH11255715A (ja) * 1998-03-13 1999-09-21 Kao Corp Ｎ，ｎ−ジ置換アニリン誘導体
US20020006418A1 (en) * 1998-10-13 2002-01-17 John Kung Composition to enhance permeation of topical skin agents
FR2792650B1 (fr) * 1999-04-20 2003-02-28 Oreal Equivalent de peau agee, son procede de preparation et son utilisation
WO2000066599A1 (en) * 1999-04-30 2000-11-09 Oberthuer Walter Antioxidative vitamin b6 analogs
JP2002543129A (ja) * 1999-05-05 2002-12-17 メルク エンド カムパニー インコーポレーテッド 抗微生物剤としての新規なプロリン類
US20020006394A1 (en) * 2000-02-11 2002-01-17 Redmond Robert W. Photochemical tissue bonding
US6464992B2 (en) * 2000-04-14 2002-10-15 University Of Kentucky Research Foundation Topical micronutrient delivery system and uses thereof
US20030185864A1 (en) * 2000-07-19 2003-10-02 Asako Kobayashi Preventives or remedies for atopic dermatitis
JP2002128651A (ja) * 2000-10-25 2002-05-09 Kose Corp 光老化抑制剤およびそれを含有することを特徴とする皮膚外用剤
CA2436300A1 (en) * 2001-02-05 2002-08-15 L. Stephen Buchanan Multi-tapered dental files
MXPA04010228A (es) * 2002-04-19 2005-06-08 Univ Arizona Metodos para modular la fotoxicidad.
DE102005000868A1 (de) * 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren

Also Published As

Publication number Publication date
RU2004133322A (ru) 2005-08-10
HK1077761B (zh) 2007-05-25
CA2668311A1 (en) 2003-10-30
CA2668311C (en) 2011-08-02
JP2010163461A (ja) 2010-07-29
CN1298321C (zh) 2007-02-07
CY1112194T1 (el) 2015-12-09
AU2003234119A1 (en) 2003-11-03
US6992071B2 (en) 2006-01-31
ES2367258T3 (es) 2011-10-31
DK1496891T3 (da) 2011-10-24
IL164560A0 (pt) 2005-12-18
CA2482320A1 (en) 2003-10-30
US7226937B2 (en) 2007-06-05
AU2003234119B2 (en) 2007-02-08
JP2005534625A (ja) 2005-11-17
ATE516802T1 (de) 2011-08-15
JP5244150B2 (ja) 2013-07-24
EP1496891B1 (en) 2011-07-20
RU2301800C2 (ru) 2007-06-27
US20060009416A1 (en) 2006-01-12
US20030223941A1 (en) 2003-12-04
JP4527405B2 (ja) 2010-08-18
EP1496891A4 (en) 2009-10-21
MXPA04010228A (es) 2005-06-08
HK1077761A1 (en) 2006-02-24
IL203968A0 (en) 2011-07-31
CA2482320C (en) 2010-02-09
IL203968A (en) 2013-02-28
NZ535982A (en) 2006-10-27
US20050042188A1 (en) 2005-02-24
CN1646121A (zh) 2005-07-27
EP1496891A2 (en) 2005-01-19
WO2003088909A2 (en) 2003-10-30
WO2003088909A3 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EP1650597A4 (en) LASER LIGHT SOURCE
RS20050946A (en) Pyrrolodihydroisoquinolines as pde10 inhibitors
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
SG145694A1 (en) Novel compounds
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
NO20075412L (no) Fremgangsmater og preparater til modulering av hyperstabilisert C-MET
ATE520674T1 (de) Natriumkanalblocker
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
DE602004010791D1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
EP1787160A4 (en) ARRANGEMENT FOR DIRECTING A MIRROR OR A SOURCE OF LIGHT
EA201000566A1 (ru) Гетероциклические сетр ингибиторы
EA200800889A1 (ru) Гексагидроциклооктилпиразольные каннабиноидные модуляторы
EA200700702A1 (ru) Аналоги локсапина и способы их применения
HK1083202A1 (en) Anti-infarction molecules
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
ATE430148T1 (de) Neue pyrrolodihydroisochinoline als pde10- inhibitoren
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
TW200609226A (en) New isobenzoxazinones and their use as ultraviolet light absorbers
IL203968A0 (en) Photodamage modulator for treating uv photodamage
DE60325194D1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
EA200800890A1 (ru) Модуляторы гексагидроциклогептапиразол каннабиноида
AT501081B8 (de) Led sowie led-lichtquelle
GB2388956B (en) Pumping light source for laser-active media